Table 17.

Response and toxicity results of daunorubicin + ara-C ± cyclosporin A in acute myeloid leukemia (AML).*

ParameterNumberYes
*Data from List et al.58  
Complete remission, % 33 39 
Death, % 18 14 
↑ Bili grade 4, % 30 
2-year relapse-free survival, % 34 
2-year survival, % 12 22 
ParameterNumberYes
*Data from List et al.58  
Complete remission, % 33 39 
Death, % 18 14 
↑ Bili grade 4, % 30 
2-year relapse-free survival, % 34 
2-year survival, % 12 22 
Close Modal

or Create an Account

Close Modal
Close Modal